These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 15532190)
21. Maraviroc (Celsentri) for multidrug-resistant human immunodeficiency virus (HIV)-1. Ndegwa S Issues Emerg Health Technol; 2007 Dec; (110):1-8. PubMed ID: 18080399 [TBL] [Abstract][Full Text] [Related]
22. The genetic cohorts: facing the new challenges in infectious diseases. The HIV model. Telenti A Enferm Infecc Microbiol Clin; 2004; 22(6):337-41. PubMed ID: 15228901 [TBL] [Abstract][Full Text] [Related]
23. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M; Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534 [TBL] [Abstract][Full Text] [Related]
24. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. Wolbers M; Bucher HC; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M; HIV Med; 2008 Jul; 9(6):397-405. PubMed ID: 18410354 [TBL] [Abstract][Full Text] [Related]
25. Gender differences in HIV infection: is there a problem? Analysis from the SCOLTA cohorts. Menzaghi B; Ricci E; Vichi F; De Sociod GV; Carenzi L; Martinelli C; Franzetti M; Orofino G; Madeddu G; Parruti G; Penco G; Grosso C; Di Biagio A; Bonfanti P; Quirino T; Biomed Pharmacother; 2014 Apr; 68(3):385-90. PubMed ID: 24613008 [TBL] [Abstract][Full Text] [Related]
26. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. Ma A; Chen DM; Chau FM; Saberi P AIDS Care; 2010 Oct; 22(10):1189-94. PubMed ID: 20640958 [TBL] [Abstract][Full Text] [Related]
27. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ J Infect Dis; 2015 Feb; 211(4):529-38. PubMed ID: 25170105 [TBL] [Abstract][Full Text] [Related]
28. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). Farinpour R; Miller EN; Satz P; Selnes OA; Cohen BA; Becker JT; Skolasky RL; Visscher BR J Clin Exp Neuropsychol; 2003 Aug; 25(5):654-70. PubMed ID: 12815503 [TBL] [Abstract][Full Text] [Related]
29. HIV disease progression in Australia in the time of combination antiretroviral therapies. Correll PK; Law MG; McDonald AM; Cooper DA; Kaldor JM Med J Aust; 1998 Nov; 169(9):469-72. PubMed ID: 9847898 [TBL] [Abstract][Full Text] [Related]
30. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371 [TBL] [Abstract][Full Text] [Related]
31. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Elzi L; Marzolini C; Furrer H; Ledergerber B; Cavassini M; Hirschel B; Vernazza P; Bernasconi E; Weber R; Battegay M; Arch Intern Med; 2010 Jan; 170(1):57-65. PubMed ID: 20065200 [TBL] [Abstract][Full Text] [Related]
32. [The Swiss HIV Cohort Study--multifaceted network supporting patient care as well as large international research projects]. Flepp M; Ledergerber B Ther Umsch; 2004 Oct; 61(10):635-8. PubMed ID: 15532194 [TBL] [Abstract][Full Text] [Related]
33. Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients. Orlando G; Meraviglia P; Cordier L; Meroni L; Landonio S; Giorgi R; Fasolo M; Faggion I; Riva A; Zambelli A; Beretta R; Gubertini G; Dedivitiis G; Jacchetti G; Cargnel A HIV Med; 2006 Nov; 7(8):549-57. PubMed ID: 17105515 [TBL] [Abstract][Full Text] [Related]
34. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. Young J; De Geest S; Spirig R; Flepp M; Rickenbach M; Furrer H; Bernasconi E; Hirschel B; Telenti A; Vernazza P; Battegay M; Bucher HC; BMJ; 2004 Jan; 328(7430):15. PubMed ID: 14703538 [TBL] [Abstract][Full Text] [Related]
35. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women. Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709 [TBL] [Abstract][Full Text] [Related]
36. [The Swiss HIV Cohort Study: from research to health care]. Vernazza P Ther Umsch; 2004 Oct; 61(10):591-2. PubMed ID: 15532185 [No Abstract] [Full Text] [Related]
37. Long-Acting HIV Treatment Superior to Daily Oral Drugs. Harris E JAMA; 2024 Mar; 331(12):1001-1002. PubMed ID: 38446434 [No Abstract] [Full Text] [Related]
38. Untangling the causal ties between antiretrovirals and obesity. Manne-Goehler J; Siedner MJ Lancet HIV; 2024 Oct; 11(10):e650-e651. PubMed ID: 39186941 [No Abstract] [Full Text] [Related]
39. HIV infection and stroke: if not protein S deficiency then what explains the relationship? Qureshi AI J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1331. PubMed ID: 16170070 [No Abstract] [Full Text] [Related]
40. Towards a cure for human immunodeficiency virus. Pitman MC; Lewin SR Intern Med J; 2018 Jan; 48(1):12-15. PubMed ID: 29314511 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]